We have located links that may give you full text access.
Apnea-Hypopnea Event Duration Predicts Mortality in Men and Women in the Sleep Heart Health Study.
American Journal of Respiratory and Critical Care Medicine 2018 October 20
RATIONALE: Obstructive sleep apnea is a risk factor for mortality, but its diagnostic metric-the apnea-hypopnea index-is a poor risk predictor. This apnea-hypopnea index does not capture the range of physiological variability within and between patients, such as degree of hypoxemia and sleep fragmentation, that reflect differences in pathophysiological contributions of airway collapsibility, chemoreceptive negative feedback loop gain, and arousal threshold.
OBJECTIVE: To test whether respiratory event duration, a heritable sleep apnea trait reflective of arousal threshold, predicts all-cause mortality.
METHODS: Mortality risk as a function of event duration was estimated by Cox proportional hazards in the Sleep Heart Health Study, a prospective community-based cohort. Gender-specific hazard ratios were also calculated.
MEASUREMENTS AND MAIN RESULTS: Among 5712 participants, 1290 deaths occurred over 11 years of follow-up. After adjusting for demographic factors (mean age 63 years old; 52% female), apnea-hypopnea index (mean 13.8; standard deviation 15.0), smoking, and prevalent cardio-metabolic disease, individuals with the shortest duration events had a significant hazard ratio for all-cause mortality of 1.31 [95% confidence interval: 1.11-1.54]. This relationship was observed in both men and women and was strongest in those with moderate sleep apnea (hazard ratio = 1.59 [1.11-2.28]).
CONCLUSIONS: Short respiratory event duration, a marker for low arousal threshold, predicts mortality in men and women. Individuals with shorter respiratory events may be predisposed to increased ventilatory instability and/or have augmented autonomic nervous system responses that increase the likelihood of adverse health outcomes, underscoring the importance of assessing physiological variation in obstructive sleep apnea.
OBJECTIVE: To test whether respiratory event duration, a heritable sleep apnea trait reflective of arousal threshold, predicts all-cause mortality.
METHODS: Mortality risk as a function of event duration was estimated by Cox proportional hazards in the Sleep Heart Health Study, a prospective community-based cohort. Gender-specific hazard ratios were also calculated.
MEASUREMENTS AND MAIN RESULTS: Among 5712 participants, 1290 deaths occurred over 11 years of follow-up. After adjusting for demographic factors (mean age 63 years old; 52% female), apnea-hypopnea index (mean 13.8; standard deviation 15.0), smoking, and prevalent cardio-metabolic disease, individuals with the shortest duration events had a significant hazard ratio for all-cause mortality of 1.31 [95% confidence interval: 1.11-1.54]. This relationship was observed in both men and women and was strongest in those with moderate sleep apnea (hazard ratio = 1.59 [1.11-2.28]).
CONCLUSIONS: Short respiratory event duration, a marker for low arousal threshold, predicts mortality in men and women. Individuals with shorter respiratory events may be predisposed to increased ventilatory instability and/or have augmented autonomic nervous system responses that increase the likelihood of adverse health outcomes, underscoring the importance of assessing physiological variation in obstructive sleep apnea.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app